Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS) -- Ignore unavailable to you. Want to Upgrade?

To: David Wideman who wrote (170)	3/5/1998 10:49:00 AM
From: Graham Marshman	Read Replies (1) \| Respond to of 4028

Would be nice - as you say only 19 days to go. Other telomerase news (good support for the concept): Bristol-Myers Squibb Co. (BMY) formed a research collaboration with the University of Texas at Austin for the development of enzyme inhibitors that could be used to fight cancer. In a press release Thursday, Bristol-Myers said the collaboration will work toward developing inhibitors to telomerase, an enzyme that is overproduced in cancer cells and plays a key role in their ability to survive. Blocking the activity of this enzyme could inhibit the growth and spread of human tumors, Bristol-Myers said. Bristol-Myers will fund the three-year collaboration, and will provide payments to the university for successfully meeting certain research goals. In return, Bristol-Myers will get exclusive worldwide rights to any lead compounds arising from the collaboration. The university would get royalties from the sale of any marketed products. Specific financial terms weren't disclosed.